Faron Pharmaceuticals Share News (FARN)

Faron Pharmaceuticals Information

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes

Get Live Data

46.00 0.00 (0.00%)

Bid:

45.00

Ask:

47.00

Spread: 2.00 (4.444%)

Market Cap: £91.78m

Last checked at -

Intraday Faron Pharmaceuticals Share Chart

REMOVE ADS

Faron Pharmaceuticals taps Juho Jalkanen for CEO

Mon, 08th Apr 2024 09:17

(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.

Jalkanen, currently the group's chief operating officer, will take over from Dr Markku Jalkanen, who turns 70 later in 2024, with effect from 1 May.

"I am very happy that the AGM approved the proposals by the board of directors, creating an opportunity for the company to continue efforts on fundraising for a longer-term solution. I have worked for the company since its inception in 2006 and feel that now is the right time for me to retire as CEO of the company and leave the operative helm," said Dr Markku Jalkanen.

"The board and I have a plan for a seamless CEO transition and now is the time to make that move. I will continue to give my support to the company and the new CEO in my continuing role as board member. I also strongly believe in the promise of bexmarilimab to provide a new safe and effective cancer treatment option for a vast patient group, either as a stand-alone or combination therapy."

As of 0915 BST, Faron shares were up 1.47% at 134.45p.